Literature DB >> 7606070

Suspected ciprofloxacin-induced hepatotoxicity.

J P Villeneuve1, C Davies, J Côté.   

Abstract

OBJECTIVE: To report a case of probable ciprofloxacin-induced hepatotoxicity. CASE
SUMMARY: A 44-year-old woman developed severe hepatitis 3 weeks after initiation of a 7-day course of oral ciprofloxacin therapy. Liver biopsy showed severe hepatic necrosis, and other causes of liver injury were excluded. Liver function test results returned to normal 4 months after the appearance of jaundice. DISCUSSION: The time course of events suggested that ciprofloxacin was the cause of severe hepatitis in this patient, and other causes of hepatitis were ruled out. Hepatotoxicity has been reported with other fluoroquinolone antibiotics, and there have been previous unpublished reports to the manufacturer of possible hepatotoxicity caused by ciprofloxacin.
CONCLUSIONS: It is suggested that ciprofloxacin can cause severe hepatic injury and that healthcare providers should be aware of this possible adverse drug reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606070     DOI: 10.1177/106002809502900305

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  9 in total

Review 1.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

3.  Prolonged cholestasis induced by endoscopic retrograde cholangiopancreatography.

Authors:  Olomuza Patani; Sian L Foulkes; Ramatoulie Njie; Richard J Aspinall
Journal:  Frontline Gastroenterol       Date:  2010-05-14

Review 4.  Antibacterial-induced hepatotoxicity. Incidence, prevention and management.

Authors:  D K George; D H Crawford
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

5.  Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.

Authors:  D W Clark; D Layton; L V Wilton; G L Pearce; S A Shakir
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Cholestatic jaundice induced by ciprofloxacin.

Authors:  J K Labowitz; W B Silverman
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.487

Review 7.  Ciprofloxacin-induced acute liver injury: case report and review of literature.

Authors:  Annette Zimpfer; Albert Propst; Gregor Mikuz; Wolfgang Vogel; Luigi Terracciano; Sylvia Stadlmann
Journal:  Virchows Arch       Date:  2004-01       Impact factor: 4.064

Review 8.  Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.

Authors:  Milan Radovanovic; Tetyana Dushenkovska; Ivan Cvorovic; Natasa Radovanovic; Vimala Ramasamy; Katarina Milosavljevic; Jelena Surla; Mladen Jecmenica; Miroslav Radulovic; Tamara Milovanovic; Igor Dumic
Journal:  Am J Case Rep       Date:  2018-09-29

9.  Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation.

Authors:  Carly Unger; Layth S Al-Jashaami
Journal:  Am J Case Rep       Date:  2016-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.